	US 11,877,981 B2
	Container for personal health compositions
Michael Devon Hayes, West Chester, OH (US); Leigh Mahoney, Liberty Township, OH (US); Lonnie Stuckert, Wilmington, OH (US); Greg Veintimilla, Maineville, OH (US); and Gary Vernon, Sugar Hill, GA (US)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by The Procter & Gamble Company, Cincinnati, OH (US); and PolyOne Corporation, Avon Lake, OH (US)
Filed on Dec. 5, 2019, as Appl. No. 16/704,287.
Claims priority of provisional application 62/775,422, filed on Dec. 5, 2018.
Prior Publication US 2020/0179223 A1, Jun. 11, 2020
Int. Cl. A61J 1/03 (2023.01); B29C 49/00 (2006.01); C09B 1/20 (2006.01); A61K 9/08 (2006.01); A61K 31/4045 (2006.01)

CPC A61J 1/03 (2013.01) [B29C 49/0005 (2013.01); C09B 1/207 (2013.01); A61J 2200/50 (2013.01); A61K 9/08 (2013.01); A61K 31/4045 (2013.01)]

10 Claims

1. A product comprising:

(a) a container, wherein the container is a bottle that mitigates photodegradation of melatonin by selectively filtering or blocking light at wavelengths selected from about 470 nm to about 540 nm and from about 620 nm to about 640 nm, the container comprising:

(i) from about 98.94% to about 99.61%, by weight of the container, of a polyester;

(ii) a colorant composition comprising:

(1) from about 0.14% to about 0.30%, by weight of the container, of a first anthraquinone dye,

(2) from about 0.05% to about 0.08%, by weight of the container, of a second anthraquinone dye, and

(3) from about 0.20% to about 0.48%, by weight of the container, of titanium dioxide; and

(b) a liquid composition comprising melatonin.